Extension of Time to File SOU

ALISEY

CHIESI FARMACEUTICI S.P.A.

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88226939
LAW OFFICE ASSIGNED LAW OFFICE 120
MARK SECTION
MARK ALISEY (see, http://uspto.report/TM/88226939/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT ALISEY
OWNER SECTION (current)
NAME CHIESI FARMACEUTICI S.P.A.
MAILING ADDRESS Via Palermo 26/A
CITY PARMA
ZIP/POSTAL CODE 43122
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Italy
EMAIL XXXX
OWNER SECTION (proposed)
NAME CHIESI FARMACEUTICI S.P.A.
MAILING ADDRESS Via Palermo 26/A
CITY PARMA
ZIP/POSTAL CODE 43122
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Italy
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Anthony P. Venturino
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE iplaw@vorys.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) apventurino@vorys.com; ybourne@vorys.com
CORRESPONDENCE INFORMATION (proposed)
NAME Anthony P. Venturino
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE iplaw@vorys.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) apventurino@vorys.com; ybourne@vorys.com
DOCKET/REFERENCE NUMBER 72924-000837
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceutical preparations and substances for the treatment of pain, alimentary tract and metabolism problems, respiratory diseases, oncological, ophthalmological, neurological, and hormonal diseases and disorders; anti-inflammatory and anti-rheumatics drugs; pharmaceutical preparations, namely, immunomodulatory; Enzyme replacement therapy preparations; enzyme replacement therapy products, namely, infusions, liquids, tablets and powders for human use in the treatment of genetic disorders for medical purposes; Therapeutic cellular and stem cell compositions for medical use
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 3
ONGOING EFFORT market research
ALLOWANCE MAIL DATE 07/16/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /anthony p venturino/
SIGNATORY'S NAME Anthony P. Venturino
SIGNATORY'S POSITION Attorney of record, DC Bar member
DATE SIGNED 12/16/2020
SIGNATORY'S PHONE NUMBER 2024678848
FILING INFORMATION
SUBMIT DATE Wed Dec 16 13:43:17 ET 2020
TEAS STAMP USPTO/ESU-XXX.XX.XXX.XXX-
20201216134317061134-8822
6939-7506fad97fd45a8cf3be
33ed1a0b6a88c7f263dab3e73
1230eb31282b3c1a05d-DA-43
165011-202012161205577543
06



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: ALISEY (see, http://uspto.report/TM/88226939/mark.png)
SERIAL NUMBER: 88226939

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: CHIESI FARMACEUTICI S.P.A., having an address of
      Via Palermo 26/A
      PARMA, 43122
      Italy
      Email: XXXX
Proposed: CHIESI FARMACEUTICI S.P.A., having an address of
      Via Palermo 26/A
      PARMA, 43122
      Italy
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 07/16/2019.

For International Class 005:
Current identification: Pharmaceutical preparations and substances for the treatment of pain, alimentary tract and metabolism problems, respiratory diseases, oncological, ophthalmological, neurological, and hormonal diseases and disorders; anti-inflammatory and anti-rheumatics drugs; pharmaceutical preparations, namely, immunomodulatory; Enzyme replacement therapy preparations; enzyme replacement therapy products, namely, infusions, liquids, tablets and powders for human use in the treatment of genetic disorders for medical purposes; Therapeutic cellular and stem cell compositions for medical use

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: market research

Correspondence Information (current):
      Anthony P. Venturino
      PRIMARY EMAIL FOR CORRESPONDENCE: iplaw@vorys.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): apventurino@vorys.com; ybourne@vorys.com

Correspondence Information (proposed):
      Anthony P. Venturino
      PRIMARY EMAIL FOR CORRESPONDENCE: iplaw@vorys.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): apventurino@vorys.com; ybourne@vorys.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /anthony p venturino/      Date Signed: 12/16/2020
Signatory's Name: Anthony P. Venturino
Signatory's Position: Attorney of record, DC Bar member
Signatory's Phone: 2024678848

RAM Sale Number: 88226939
RAM Accounting Date: 12/16/2020

Serial Number: 88226939
Internet Transmission Date: Wed Dec 16 13:43:17 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XX.XXX.XXX-202012161343170
61134-88226939-7506fad97fd45a8cf3be33ed1
a0b6a88c7f263dab3e731230eb31282b3c1a05d-
DA-43165011-20201216120557754306




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed